Drug shortages in European countries: A trade-off between market attractiveness and cost containment?

BMC Health Services Research

Volumn 14, Issue 1, 2014, Pages

  Pauwels, Kim ^a   Huys, Isabelle ^a   Casteels, Minne ^a   Simoens, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Drug shortage; Drug supply; Health policy

Indexed keywords

DRUG;

COMMERCIAL PHENOMENA; COST CONTROL; CROSS-SECTIONAL STUDY; ECONOMICS; EUROPE; HEALTH CARE POLICY; INFORMATION PROCESSING; SUPPLY AND DISTRIBUTION;

COMMERCE; COST CONTROL; CROSS-SECTIONAL STUDIES; DATA COLLECTION; EUROPE; HEALTH POLICY; PHARMACEUTICAL PREPARATIONS;

EID: 84908136574     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-438     Document Type: Article

References (22)

1. Gray A, Manasse HR: Shortage of medicines: a complex global challenge. Bull World Health Organ 2012, 90:154A-154A.
2. McBride A, Holle LM, Westendorf C, Sidebottom M, Griffith N, Muller RJ, Hoffman JM: National survey on the effect of oncology drug shortages on cancer care. Am J Health Syst Pharm 2013, 70:609-617.
3. Rider AE, Templet DJ, Daley MJ, Shuman C, Smith LV: Clinical dilemmas and a review of strategies to manage drug shortages. J Pharm Pract 2013, 26:183-191.
4. Mayer DK: Anatomy of a drug shortage. Clin J Oncol Nurs 2012, 16:107-108.
5. Ventola CL: The drug shortage crisis in the United States: causes, impact, and management strategies. P T 2011, 36:740-757.
6. Kweder SL, Dill S: Drug shortages: the cycle of quantity and quality. Clin Pharmacol Ther 2013, 93:245-251.
7. IMS institute: Drug Shortages: A Closer Look at Products, Suppliers and Volume Volatility. [http://www.imshealth.com/portal/site/ims/menuitem.edb2b81823f67dab41d84b903208c22a/?vgnextoid=a6fbcc0f68f73310VgnVCM100000ed152ca2RCRD]
8. Dal MF: BCG shortage in Europe. Prev Med 2013, 57:146.
9. Giraldo P, Irun P, Alfonso P, Dalmau J, Fernandez-Galan MA, Figueredo A, Hernandez-Rivas JM, Julia A, Luno E, Marin-Jimenez F, Martin-Nunez G, Montserrat JL, de la Serna J, Vidaller A, Villalon L, Pocovi M: Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage. Blood Cells Mol Dis 2011, 46:115-118.
10. Linthorst GE, Burlina AP, Cecchi F, Cox TM, Fletcher JM, Feldt-Rasmussen U, Giugliani R, Hollak CE, Houge G, Hughes D, Kantola I, Lachmann R, Lopez M, Ortiz A, Parini R, Rivera A, Rolfs A, Ramaswami U, Svarstad E, Tondel C, Tylki-Szymanska A, Vujkovac B, Waldek S, West M, Weidemann F, Mehta A: Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in Europe, following a period of shortage. JIMD Rep 2013, 8:51-56.
11. Tirelli U, Berretta M, Spina M, Michieli M, Lazzarini R: Oncologic drug shortages also in Italy. Eur Rev Med Pharmacol Sci 2012, 16:138-139.
12. Furness H: Drug shortage caused by sale to EU. Telegraph; 2012. 15-5.
13. European Association of Hospital Pharmacists: Medicine shortages in European hospitals. [http://www.eahp.eu/practice-and-policy/medicines-shortages]
14. Capstick TG, Laycock D, Lipman MC: Treatment interruptions and inconsistent supply of anti-tuberculosis drugs in the United Kingdom. Int J Tuberc Lung Dis 2011, 15:754-760.
15. World Health Organization (WHO): WHO Model Lists of Essential Medicines. [http://www.who.int/medicines/publications/essentialmedicines/en/]
16. World Health Collaborating Centre for Drug Statistics and Methodology: ATC/DDD Index 2013. [http://www.whocc.no/atc-ddd-index/]
17. Woodcock J, Wosinska M: Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther 2013, 93:170-176.
18. Food and Drug Administration: Strategic Plan for Preventing and Mitigating Drug Shortages. [http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM372566.pdf]
19. Food and Drug Administration: FDA acts to prevent more drug shortages. [http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm370495.htm]
20. European Association of Pharmaceutical Full-line Wholesalers: Medicine shortages in Europe and their impact on patients - a reflection paper. [http://www.girp.eu/sites/default/files/documents/Medicines%20shortages%20reflection%20paper%20including%20exec.%20summary%20FINAL.pdf]
21. Dylst P, Vulto A, Simoens S: Tendering for outpatient prescription pharmaceuticals: what can be learned from current practices in Europe? Health Policy 2011, 101:146-152.
22. Bart TN: Parallel trade of pharmaceuticals: a review of legal, economic, and political aspects. Value Health 2008, 11:996-1005.